{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-082414","form_type":"8-K","ticker":"CTSO","cik":"0001175151","company_name":"Cytosorbents Corp","filed_at":"2023-07-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.311197+00:00","generated_at":"2026-06-13T06:15:50.943360+00:00","sec_items":["1.01","5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"CytoSorbents appoints Alexander D'Amico as CFO effective August 7, 2023","bullets":["Annual base salary of $425,000; eligible for cash bonus up to 45% of salary based on milestones.","Received signing bonus of $5,000 and equity awards including 70,000 ISOs, 45,000 RSUs, 215,000 performance ISOs.","Employment agreement initial term through Dec 31, 2025, auto-renewing annually thereafter.","D'Amico previously CFO of Trulieve Cannabis; oversaw finance during revenue growth from $250M to $1.2B.","Outgoing CFO Kathy Bloch retiring after decade of service; transition managed."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-082414","json":"https://secwatch.observer/filing/0001104659-23-082414.json","markdown":"https://secwatch.observer/filing/0001104659-23-082414.md","text":"https://secwatch.observer/filing/0001104659-23-082414.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1175151/000110465923082414/0001104659-23-082414-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1175151/000110465923082414/tm2321613d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T06:15:50.943360+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"f7d3deff02","claim":"Alexander D'Amico was appointed as Chief Financial Officer at Cytosorbents Corp.","evidence_excerpt":"Mr. D’Amico will serve as the Company’s Chief Financial Officer, effective as of August 7, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1175151/000110465923082414/0001104659-23-082414-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}